Video

New Phase I/II Trial Using Multimodal PDT for Advanced, Recurrent Colorectal Cancer

Long a pioneer in innovative treatments for colorectal cancer, Roswell Park Comprehensive Cancer Center is recruiting patients with locally advanced or recurring colorectal cancer for a new trial involving photodynamic therapy, a technology ...

News

Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference

Register for the Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual meeting, taking place on April 25-26 in Buffalo, NY.

News

Can Induction Improve Survival in High-Risk, Locally Advanced Cervical Cancer?

Rates of overall and progression-free survival for locally advanced cervical cancer have risen significantly since 2024, when the FDA approved the use of pembrolizumab (brand name Keytruda) with chemoradiation for stage 3-4A disease.

News

Insights on Sarcomas, Gastroesophageal Cancers, Peritoneal Tumors Anchor Roswell Park Presentations at SSO 2026

A Roswell Park study is shedding light on the little-understood dynamics of the tumor microenvironment (TME) in two types of rare and aggressive sarcomas — dedifferentiated liposarcomas (DDLPS) and leiomyosarcomas (LMS). 

News

World Leaders in Gamma Knife Radiosurgery, Roswell Park Experts Expand Benefits and Access

Since Roswell Park Comprehensive Cancer Center first began offering Gamma Knife radiosurgery 27 years ago, the cancer center has emerged as a world leader in the procedure.

Video

Roswell Park Achieves National Accreditation for Rectal Cancer Care

Team recognized by National Accreditation Program for Rectal Cancer and American College of Surgeons.